Preoperative prostate MRI exams can offer added value in predicting biochemical recurrence (BCR) of prostate cancer and often perform comparably to post-surgical pathologic staging. That’s according to new data published in the American Journal of Roentgenology, comparing the utility of pre-surgical staging information from MRI and post-surgical staging information from radical prostatectomy (RP) pathology in predicting cancer recurrence.